ArticleBrain & spine2026
Outcome after surgery for meralgia paresthetica - a retrospective cohort study.
Article in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Meralgia paresthetica may cause chronic pain and sensory disturbances. When conservative treatment fails, surgery with neurolysis or neurectomy is considered, but evidence remains limited. Research question: To evaluate pain relief, sensory outcomes, and durability after surgical treatment of meralgia paresthetica. Methods: In this single-center retrospective cohort study, all meralgia paresthetica patients treated surgically between 2019 and 2024 were included. Outcomes (pain, sensory disturbances and secondary surgery) were selected in accordance with core outcome set recommendations. Pain, measured as changes in NRS, was analyzed with Wilcoxon signed-rank tests, between-procedure differences with Mann-Whitney U tests, and time to reoperation with Kaplan-Meier analysis. Results: A total of 101 patients underwent 128 procedures. Primary neurolysis (n = 102) was associated with a median pain reduction of 6.5 NRS points ( Conclusion: Surgery for meralgia paresthetica provides substantial and durable pain relief. Neurolysis is effective as first-line surgery, with reoperations being uncommon and typically occurring within the first postoperative year. Neurectomy did not show superior pain relief and is associated with unavoidable sensory loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.